Sugammadex Injection, Solution
Product Images NDC 70710-1650

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 70710-1650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 01)

Chemical structure of sugammadex, showing its cyclic molecular arrangement with multiple hydroxyl groups and sodium carboxylate substituents as part of its molecular framework.*

FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 02)

Chemical structure of Sugammadex, depicting its cyclic molecular framework with multiple oxygen, sulfur, and sodium-containing groups arranged around the ring.*

FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 03)

A cumulative recovery rate graph comparing recovery times in minutes on the x-axis to cumulative recovery rate on the y-axis. The graph contrasts sugammadex 2 mg/kg and neostigmine 0.05 mg/kg in a sample size of 48 each, showing median recovery times and censored observations. A text box on the graph highlights median recovery times: sugammadex 1.4 minutes and neostigmine 21.5 minutes.*

FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 04)

A Kaplan-Meier cumulative recovery rate graph comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time to recovery in minutes. The graph shows a faster recovery rate with sugammadex, reaching near 1.0 cumulative recovery rate much earlier than neostigmine. Median recovery times are listed as 2.1 minutes for sugammadex and 29.0 minutes for neostigmine.*

FDA Label Image

2ml Vial (75ac6da6 477a 483f Aced F266e2e8c2a9 05)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) solution for intravenous use. The label indicates it is a single-dose vial with storage instructions at 25°C (77°F) and a warning to protect from light. Distributed by Zydus Pharmaceuticals USA Inc., Pennington, NJ. Includes fields for total dose, lot, and expiration date, with instructions to peel off and apply to syringe.*

FDA Label Image

5ml Vial (75ac6da6 477a 483f Aced F266e2e8c2a9 06)

Label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) intravenous solution. The label states it is a 5 mL single-dose vial for human prescription use only, with storage instructions and manufacturer details for Zydus Pharmaceuticals USA Inc. The label includes dosage concentration, usage notes, and space for lot and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.